Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
We'll review your health history and goals to create a personalized plan
They work through different mechanisms and may be complementary
PMC2930015 7
Novo Nordisk is the market leader: Ozempic (weekly injection for type 2 diabetes) Wegovy (higher-dose weekly injection for obesity) Rybelsus ( Oral tablets for diabetes Oral tablets for weight management is in phase 3 trials) Eli Lilly is the other major player: Mounjaro (weekly injection for type 2 diabetes) Zepbound (higherdose weekly injection for obesity) This duopoly meant that both stocks had an incredible run-up from 2020 to 2024
US$ 28.32
US$ 21.83
US$ 22.27
US$ 26.99
US$ 26.81
US$ 26.67
